The largest database of trusted experimental protocols

59 protocols using humanomni1 quad beadchip

1

Genotyping and RNA-seq Data Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotypes of DGN samples were genotyped on the Illumina HumanOmni 1-Quad BeadChip [15 (link)]. Nine hundred twenty-two samples have RNA-seq data available. We further removed related individuals and were left with 913 individuals. We imputed the genotypes on the Michigan Imputation Server [38 (link)]. We kept only SNPs with genotyping rate > 99%, minor allele frequency > 5%, and Hardy-Weinberg equilibrium < 10−6 using PLINK 2.0 [39 ].
RNA-seq reads were mapped to the reference genome (NCBI v37) by TopHat in ref. [15 (link)]. We further discarded reads that are mapped to multiple locations and reads with > 2 mismatches. Next, we removed genomic regions with low mappability. We quantified expression with HTseq [40 ]. Expression levels of 13,634 genes with at least 1CPM in at least 50% of the individuals were quantified. Finally, expression levels of these genes are quantified as Transcripts Per Million (TPM). We first quantile normalized the expression levels across samples. Then, we quantile normalized the expression levels to standard normal across genes before running testing for trans signals.
+ Open protocol
+ Expand
2

Genome-wide Association Study of Ig Levels in Kawasaki Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotype data used for GWAS of Ig levels were obtained from our previous study.15) (link) Genotyping methods and quality control steps for GWAS are also described in detail in the previous study.15) (link) Briefly, 296 children with KD were genotyped using the Illumina Human Omni1-Quad Bead Chip (Illumina, San Diego, CA, USA), according to the manufacturer's instructions. Among them, 241 patients with Ig data were included in the analysis. To filter single nucleotide polymorphism (SNP) markers, the following were excluded: 2,553 SNPs with missing call rates >2%, 413 SNP markers with a Hardy-Weinberg Equilibrium p value of <1×10−6, and 209,342 SNP markers with a minor allele frequency <0.01. After SNP filtration, 718,717 SNPs were included in the genome-wide association analysis.
+ Open protocol
+ Expand
3

Genomic DNA Extraction and TP53 Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted as described previously [18 (link), 19 (link)]. PCR direct sequencing was performed for exon 5–9 of the TP53 gene as previously described [18 (link)]. The presence of genetic alterations was investigated by single-nucleotide polymorphism- comparative genomic hybridization (SNP-CGH, HumanOmni1-Quad BeadChip; Illumina Inc.), and the copy number variation was analyzed with the software program GenomeStudio V2009.1 (Illumina Inc.) as described previously [18 (link), 20 (link)].
+ Open protocol
+ Expand
4

Tumor DNA Extraction and Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA from frozen tumor retinoblastoma specimens was isolated with the NucleoSpin Tissue kit (Macherey-Nagel, Düren, Germany). DNA quality was analyzed for high molecular bands > 20 kb by agarose gel electrophoresis. DNA concentration and OD 260/280 ratio were determined with the Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, USA). DNA yields and quality were within the same range for all samples. Microarray-based DNA genotyping experiments were performed at ServiceXS (ServiceXS B.V., Leiden, The Netherlands) using the HumanOmni1-Quad BeadChip (Illumina Inc., San Diego, U.S.A.), as described previously (Mol et al., 2014 (link)).
+ Open protocol
+ Expand
5

Genetic Profiling of Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects were genotyped using the Illumina HumanOmni1-Quad BeadChip. Table 1 summarizes the number of individuals in different categories. After quality control, 2024 samples were retained for the final analysis. Details on the study population characteristics and the quality control parameters applied on the samples and markers can be found elsewhere [17] (link), [18] . Briefly, samples were filtered if they had a missing genotype rate ≥0.02, or with mean X-chromosome heterozygosity ≥0.02 for males or outside the range of 0.25∼0.4 for females. Genetic outliers and those with evidence of relatedness (IBD estimate ≥0.4) or non-European ancestry based on genotype data were also excluded. After filtering, 496 AD+P cases, 639 AD intermediate P, 156 AD−P cases and 958 unaffected controls were retained. Markers were excluded if they had a genotype missing rate of >0.02. Markers were examined to determine if missing depended on case/control status or the genotyping batch.
+ Open protocol
+ Expand
6

Genotyping and Imputation of DNA Methylation Dataset

Check if the same lab product or an alternative is used in the 5 most similar protocols
Of the 607 samples in our DNAm dataset, 590 had whole-genome genotyping data available, which was measured using the Illumina HumanOmni1-Quad BeadChip. Standard QC measures were applied: removing samples with less than 95% SNP call rate, sex discrepancies, relatedness (Pi-hat > 0.2), or excess hetero- or homozygosity. Markers with less than a 98.5% call rate, or are monomorphic were removed. Phasing was performed using SHAPEIT [25 (link)] followed by SNP imputation via the IMPUTE2 software [26 (link)], and all individuals in the 1000 Genomes Project as a reference sample. Genetic ancestry was determined using EigenStrat program [21 (link)] and eigenvectors were utilized in statistical analyses, as described in detail below. Given our interest in the role of SNPs in producing gap signals, we limited all of our analyses to the 590 samples that had both genotype and 450k data. We also limited our analysis to those SNPs with a minor allele frequency ≥0.5%, as this value corresponded to the same number of individuals that would be allowed in the smallest gap signal group according to the default input arguments (see “gap hunting” algorithm section).
+ Open protocol
+ Expand
7

Pharmacogenomic Evaluation of Antihypertensive Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Details of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study have been published.14 (link) Briefly, PEAR-enrolled patients with essential hypertension were randomized into atenolol or HCTZ treatment groups. After a washout period of approximately 4 weeks, the patients were treated as per protocol for an average of 9 weeks. The BP response to monotherapy was assessed using a composite of home, ambulatory, and clinic BP measurements before the “other” drug was added on for another 9 weeks and response to the dual therapy was assessed similarly. For the purpose of this study, we focused on the BP response to atenolol and HCTZ monotherapy in 227 Euro-Americans and 147 African-American patients. Genotypes were determined using Illumina Human Omni1-Quad BeadChip (Illumina, San Diego CA). Genotype imputation was performed using MaCH software program (version 1.0.16) with SNPs that passed quality-control filtering and HapMap III-phased haplotypes as reference panel. SNX1 SNPs were defined as those ± 5 kb from SNX1 (n = 12 SNPs).
+ Open protocol
+ Expand
8

Comprehensive GWAS Panel Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
To represent the characteristics of a typical GWAS panel, markers from the Affymetrix Genome-Wide Human SNP Array 6.0, the Illumina Human1M–Duo Genotyping BeadChip, and the Illumina HumanOmni1-Quad BeadChip were downloaded from the UCSC genome browser, using the table browser tool [24] . The union of these three arrays consisted of 1,936,864 unique SNPs from the 22 autosomes. Because of its unique LD and genic properties, the MHC region (chr6: 29624809–33160245 on build 37) was excluded from downstream analyses.
LD proxies or “tagging” SNPs (r2> = 0.8) for the GWAS panel SNPs were identified using VCFtools [25] (link) based on data from the (N = 379) Europeans (Phase I, version 3, March 14, 2012) in the 1000 Genomes Project [26] (link).
GWAS “non-hits” were defined as all those SNPs in our union GWAS set which were neither a GWAS “hit” (see below), nor in high LD (r2> = 0.8) with a GWAS hit.
+ Open protocol
+ Expand
9

Genotyping of Germline DNA Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Germline DNA was extracted from EDTA-venous blood samples using FlexiGene DNA Kit (Qiagen). Genotyping was performed by the SNP&SEQ Technology Platform, Uppsala, Sweden, using the HumanOmni1-Quad beadchip (Illumina). Five SNPs of interest (rs11979158, rs2252586, rs4295627, rs55705857, and rs78378222) were not represented on the chip and were therefore imputed using the software IMPUTE2 with data from the 1000 Genomes Project as the reference population [17 (link)]. The imputation info scores for the imputed SNPs were 0.997, 0.939, 0.999, 0.535, and 0.795, respectively, where values near 1 indicate that a SNP has been imputed with high certainty. Due to the low imputation info score (<0.85), rs55705857 (8q24.21) and rs78378222 (in TP53, 17p13.1) were excluded from further analysis.
+ Open protocol
+ Expand
10

Genome-wide genotyping and ancestry analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Participants’ genomic DNA was genotyped for >1 million SNPs using the Illumina Human Omni1-Quad BeadChip (Illumina, San Diego, CA). The quality control steps employed have been previously published.13 (link) Principal components for ancestry were identified using the EIGENSTRAT method.21 (link) Genotype imputation was performed using MaCH (version 1.0.16) and HapMap III reference panels.22 (link) SNPs with minor allele frequency (MAF) <3% and/or imputation quality r2 <0.3 were excluded. After imputation and quality control, the final genetic dataset consisted of 758 samples (n=461 white, n=297 African American).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!